Related Experiment Video

Updated: May 15, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Why do I treat HBeAg-positive chronic hepatitis B patients with a nucleoside analogue

Hong Ma1, Jidong Jia

  • 1Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Liver International : Official Journal of the International Association for the Study of the Liver
|January 5, 2013
PubMed

Insights

Nucleos(t)ide analogues (NAs) effectively suppress chronic hepatitis B virus (HBV) DNA replication, improving liver histology and patient survival. Long-term NA therapy is crucial for managing CHB and preventing disease progression.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Chronic hepatitis B (CHB) poses a significant global health and economic challenge.
  • Persistent hepatitis B virus (HBV) replication independently predicts disease progression.
  • Sustained HBV replication suppression is key to preventing CHB progression and improving survival.

Purpose of the Study:

  • To evaluate the efficacy and safety of nucleos(t)ide analogues (NAs) in managing CHB.
  • To highlight the role of sustained viral suppression in achieving clinical benefits.
  • To discuss treatment strategies for long-term HBV DNA suppression.

Main Methods:

  • Review of pivotal clinical trials and real-world studies on NA treatment for CHB.
  • Analysis of HBV DNA suppression rates, HBeAg seroconversion, and histological outcomes.
  • Evaluation of NA safety profiles and resistance patterns.

Main Results:

  • NAs demonstrate potent HBV DNA suppression with favorable safety profiles.
  • Extended NA treatment increases HBeAg seroconversion rates.
  • Profound HBV DNA suppression leads to histological improvement and reduced disease progression, even in cirrhosis.

Conclusions:

  • NAs are the preferred first-line treatment for CHB due to high efficacy, safety, and proven clinical benefits.
  • Long-term NA therapy can lead to sustained viral suppression and histological improvement.
  • Treatment strategies should prioritize potent, low-resistance regimens for optimal long-term outcomes.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...